Moreover, it was showed that breast cancer cells overexpressing CXCR4 metastasize to distant sites, where SDF-1 is highly expressed [18, 48], raising the possibility that targeted therapies against SDF-1/CXCR4 axis may inhibit tumor growth, as described in vitro [49–54]. This evidence concerns the gene CXCL12 and breast carcinoma.